menu
    • menu

    Company profile for AB Science

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    AB Science was founded in 2001 by a team of scientists in order to develop new drugs targeting indications with unmet medical needs, in the field of cancers, chronic inflammatory diseases and neurological degenerative disorders. In human medicine, our masitinib pipeline is well advanced with several phase 3 studies in oncology and non-oncology diseases and promising data in Amyotrophic Lateral Sclerosis and indolent severe sys...
    AB Science was founded in 2001 by a team of scientists in order to develop new drugs targeting indications with unmet medical needs, in the field of cancers, chronic inflammatory diseases and neurological degenerative disorders. In human medicine, our masitinib pipeline is well advanced with several phase 3 studies in oncology and non-oncology diseases and promising data in Amyotrophic Lateral Sclerosis and indolent severe systemic mastocytosis. Masitinib is already commercialized in veterinary medicine and we celebrated in 2018 the 10th anniversary of the EMA marketing authorization of our product Masivet.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AB ScienceFrance Flag
    Country
    Country
    France
    Address
    Address
    3, Avenue George V 75008 PARIS
    Telephone
    Telephone
    +33 (0)1 47 20 00 14
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ab-science.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AB Science: Early Masitinib Benefits in ALS Published on MedRxiv
    AB Science: Early Masitinib Benefits in ALS Published on MedRxiv

    11 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/11/3204198/0/en/AB-Science-announces-new-publication-on-Medrxiv-highlighting-clinical-benefit-with-masitinib-in-Amyotrophic-Lateral-Sclerosis-patients-prior-any-complete-loss-of-function.html

    GLOBENEWSWIRE
    11 Dec 2025
    Share Share
    AB Science Completes EUR 2.8M Private Placement
    AB Science Completes EUR 2.8M Private Placement

    17 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/17/3168444/0/en/AB-Science-announces-the-successful-completion-of-a-EUR-2-8-million-private-placement.html

    GLOBENEWSWIRE
    17 Oct 2025
    Share Share
    AB Science Reports Early Ph1 Data of AB8939 + Venetoclax in AML
    AB Science Reports Early Ph1 Data of AB8939 + Venetoclax in AML

    16 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/16/3168256/0/en/AB-Science-provides-intitial-Phase-1-data-for-the-combination-of-AB8939-with-venetoclax-for-the-treatment-of-refractory-or-relapsed-acute-myeloid-leukemia.html

    GLOBENEWSWIRE
    16 Oct 2025
    Share Share
    AB Science To Host Virtual Conference On AB8939 Phase 1 Study
    AB Science To Host Virtual Conference On AB8939 Phase 1 Study

    14 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/14/3165893/0/en/AB-Science-will-hold-a-virtual-conference-on-Thursday-October-16-2025-from-2pm-to-3pm-CET-to-provide-an-update-on-the-Phase-1-study-with-AB8939.html

    GLOBENEWSWIRE
    14 Oct 2025
    Share Share
    AB Science Reports First-Half 2025 Revenues And Activity Update
    AB Science Reports First-Half 2025 Revenues And Activity Update

    10 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/10/3165017/0/en/AB-Science-today-reports-its-revenues-for-the-first-half-of-2025-and-provides-an-update-on-its-activities.html

    GLOBENEWSWIRE
    10 Oct 2025
    Share Share
    Ab Science Delays 2025 Half-Year Financial Report Publication
    Ab Science Delays 2025 Half-Year Financial Report Publication

    30 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/30/3158953/0/en/AB-Science-announces-a-slight-delay-in-the-publication-of-its-2025-half-year-financial-report.html

    GLOBENEWSWIRE
    30 Sep 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search